Each 10 g syringe contains:

Cefalexin 200 mg
(as Cefalexin monohydrate)
Kanamycin monosulphate 100,000 I.U.

20 Tubes per box

Target Species

Lactating cows.

Indications for use, specifying the target species

Treatment of clinical mastitis in lactating dairy cows caused by bacteria susceptible to the combination of cefalexin and kanamycin such as Staphylococcus aureus (see section 5.1), Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.

View Product Information